🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Asparaginase (Asp) is used during the induction phase of ALL treatment for ...
Status
Terminated
Location
University of Chicago
Start Date
2013-10
Trial ID
NCT01910428
Treatments Being Tested
Pegylated-asparaginase (PEG-ASP) is an important part of the treatment of c...
Status
Completed
Location
Aahus University hospial, hematological department
Start Date
2017-08-23
Trial ID
NCT03267030
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
The protocol aims at adding GRASPA (L-asparaginase encapsulated in red bloo...
Status
Completed
Location
Hôpital l'Archet 1
Start Date
2013-02
Trial ID
NCT01810705
Treatments Being Tested
Early Access Program to provide L-asparaginase encapsulated in Erythrocyte ...
Status
No Longer Available
Location
Hôpital Jean Minjoz - Batiment MEMCP
Start Date
TBD
Trial ID
NCT02197650
Treatments Being Tested
This will be a single-arm, multi-center, open-label phase 1 study. The stan...
Status
Completed
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2020-12-02
Trial ID
NCT04292743
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 2/3 study in patients...
Status
Terminated
Location
ZNA Middelheim
Start Date
2019-06-13
Trial ID
NCT03674242
Treatments Being Tested